The Pune-based Mylab Discovery Solutions has launched a machine which will reduce human efforts and operational costs to carry out clinical tests on Covid-19 patients.
The machine called ”Compact XL” can automate the manual processes of molecular diagnostic tests, including RT-PCR tests for COVID-19. At the same time, the cartridge-based machine can test as many as 32 samples at a time.
Compact XL is a compact bench-top machine that will automate lab processes from sample handling to preparing the Reverse Transcription Polymerase Chain Reaction (RT-PCR) ready tubes, a PTI report said.
“It can be used for a wide range of RNA/DNA-based tests including COVID-19 RT-PCR tests. The machine can take input of various sample types such as plasma, tissue, sputum and swab,” the firm said in a release.
The machine was unveiled at Serum Institute of India in the presence of its chairman Cyrus Poonawalla, CEO Adar Poonawalla and AP Globale chairman Abhijeet Pawar.
In April, Mylab had announced partnering with Serum India and AP Globale to scale up the operations and escalate faster delivery of its COVID-19 testing kits.
Mylab Discovery Solutions managing director Hasmukh Rawal said that “to make India self-reliant in advanced diagnostics, Compact XL is our most ambitious project to date”.
Compact XL will replace the need of 700 sq ft of cleanroom lab with a 4×3 bench-top machine and reduce the need of 3-4 expert technicians to just one, saving operational costs for labs, Rawal said.
From the patients perspective, automated processes will eliminate errors and improve accuracy, for example, the robotic movements in the machine are precise to the tune of hundred-thousandths of a ml when handling liquids, he added.